An overview of the objectives and activities planned by the different Directorates-General (DGs) of the European Commission, which are outlined in the Commission’s Management Plans for 2021.
By analysing the different Management Plans, we have identified the priorities conducted by several DGs in order to be able to engage with the European Commission according to their agenda and have leverage in conveying the VPHi & Alliance’s key messages.
Within its management plan for 2021, DG SANTE (Directorate-General for Health and Food Safety) focuses on building a strong European Health Union. The main pillars contributing to this objective are the Pharmaceutical Strategy, Europe´s Beating Cancer Plan, and the foreseen launch of the European Health Data Space. The Plan also references the upcoming EU4HealthProgramme whose actions will be implemented under the “One Health” approach. Its four sub-objectives are listed as follows:
Diminishing the impact of cancer in Europe by improving prevention and care.
Ensuring patients’ access to safe, innovative, and affordable medicines and medical devices. Activities include, among others:
Ensuring effective response coordination of serious cross-border health threats, including:
Ensuring more effective, accessible, and resilient health systems. The following activities, inter alia, will be carried out.
DG CONNECT (Directorate-General for Communications Networks, Content and Technology) will implement a substantial part of Horizon Europe, setting the strategy for research and innovation related to digital technologies.
As such, its Management Plan puts forward the following activities of relevance to Avicenna:
The launch of the calls for funding of the Digital Europe programme - which aims to establish essential digital capacities in key digital technology areas among which High Performance Computing and AI - is to be expected in Q4 2021.
A proposal a Regulation on a Horizontal Regulatory Framework on Artificial Intelligence, relating to aspects of fundamental rights and safety in Q1 2021.
As to the European Health Data Space, DG CONNECT will support the deployment of secure infrastructures that will make genomic data and cancer images securely accessible across borders and the exploration of new tools, technologies and digital solutions including health data.
Launch of the next phrase of the Brain Project Flagship that provides an infrastructure for researchers to advance in neuroscience, computing, including neuromorphic computing, and brain-related medicine in Q1 2021.
The launch of the Public-Private Partnership in AI, Data and Robotics in Q1 2021.
The JRC will remain supporting the fight against COVID-19. Correspondingly, its activities will focus on six strategic priorities, among which: epidemiological monitoring, modelling and reporting, use of alternative data and digital technologies, diagnostics and health, as well as socio-economic modelling and analysis.
For the European Health Data Space, the JRC will provide evidence related to heath data in terms of data quality, standardisation, interoperability, governance and analysis (including the use of AI). Both the JRC’s cancer and rare diseases registries will serve as a pilot of the EU Data Space:
Activities put forward by DG RTD plan‘s include, among others:
Contributing to the implementation of the Communication on enabling the digital transformation of health and care in the Digital Single Market in Q4 2021.
Connecting the European Health Data Space to the European Open Science Cloud (EOSC) in Q2 2021.
Introduction of an EIC Accelerator challenge to support game-changing innovations and technologies in strategic digital and health technologies by end of 2021.
Launch of the Innovative Health Initiative partnership following the adoption of the legal base in Q4.
A report by Renée Frijns, Avicenna Alliance Secretariat.